2024-09-03 - Analysis Report
## HCA Stock Analysis Report

**Company Overview:** HCA Healthcare, Inc. is a leading healthcare provider in the United States, operating hospitals, surgery centers, and other healthcare facilities. 

**1. Performance Comparison:**
HCA's cumulative return of 170.42% significantly outperforms the S&P 500's (VOO) 89.66%. This difference, at 80.76%, places HCA in the top 100% of its historical performance relative to the S&P 500.

**2. Recent Price Movements:**
* **Closing Price:** $395.59
* **5-day Moving Average:** $391.45
* **20-day Moving Average:** $373.99
* **60-day Moving Average:** $348.09

The stock price is currently above all three moving averages, indicating a potential upward trend.

**3. Technical Indicators:**
* **RSI:** 99.19 -  This indicates the stock is currently in overbought territory, suggesting a potential pullback.
* **PPO:** 0.22 -  A positive PPO value signals potential bullish momentum.
* **Delta_Previous_Relative_Divergence:** +1.17 -  This positive value indicates a recent increase in the stock's relative divergence, suggesting potential upward pressure.
* **Expected_Return:** 0.0% - This suggests a potential for moderate returns in the next 5 years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | $17.49 B |
| 2024-05-02 | 6.01 | $17.34 B |
| 2023-10-26 | 3.98 | $16.21 B |
| 2023-08-02 | 4.35 | $15.86 B |
| 2024-07-29 | 4.35 | $15.86 B |

The most recent earnings report (2024-07-29) shows a strong EPS of 5.6, exceeding expectations. This positive performance reflects a strong trend of continued revenue growth and profitability. 

**5. Overall Analysis:**

HCA has consistently outperformed the S&P 500, displaying strong fundamental strength through recent earnings and revenue growth. The stock is currently trading in overbought territory according to RSI, indicating a potential pullback. However, the positive PPO, relative divergence, and expected return suggest continued upward momentum in the long term. 

**6. Conclusion:**

While the stock is currently overbought, HCA's strong financial performance and positive technical indicators suggest a continued bullish outlook.  However, investors should be mindful of potential short-term corrections due to the high RSI value. The long-term outlook remains positive, supported by the company's consistent revenue growth and robust financial position.